Sodium Chloride and Contrast Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.
Also called NCT03476460
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 271 participants
- Sponsor
- Registry
-
NCT03476460
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT03476460. Randomized; no masking; primary purpose prevention. Start 2014-04-01 (actual); primary completion 2019-11-29 (actual). Results posted on 2025-03-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sodium Chloride and Contrast Nephropathy
- Acronym
- PNIC-Na
- Condition
- Kidney Failure, Chronic
- Condition
- Kidney Failure, Acute
- Condition
- Heart Failure
- Condition
- Diabetes
- Intervention (Drug)
- Oral sodium chloride
- Intervention (Drug)
- Intravenous sodium chloride
- Lead sponsor
- Hospital Universitario Ramon y Cajal
- Collaborator
- Instituto de Salud Carlos III
- Collaborator
- Ministerio de Sanidad, Servicios Sociales e Igualdad
Record details
- Record id
cardio:ct-nct03476460- Content hash
7ff7b1fd2de18dcc8b31ba97ea7f40780d95bef0362ad493087d17b4b508fd4d